• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.

作者信息

Lenaz L, Di Marco A

出版信息

Cancer Chemother Rep. 1972 Aug;56(4):431-2.

PMID:5081585
Abstract
摘要

相似文献

1
On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
Cancer Chemother Rep. 1972 Aug;56(4):431-2.
2
Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):671-6.
3
Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).通过与顺二氨二氯铂（NSC - 119875）或柔红霉素（NSC - 82151）联合使用增强ICRF - 159（NSC - 129943）对早期L1210白血病的抗肿瘤效果。
Cancer Chemother Rep 2. 1974 Mar;4(1):45-52.
4
Mammary tumors induced in rats by adriamycin and daunomycin.阿霉素和柔红霉素诱导大鼠产生的乳腺肿瘤。
Cancer Res. 1978 May;38(5):1444-6.
5
Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
Cancer Chemother Rep. 1974 May-Jun;58(3):293-4.
6
Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
Cancer Chemother Rep. 1975 Jul-Aug;59(4):707-15.
7
DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA.DNA-蒽环类复合物。I.柔红霉素-DNA和阿霉素-DNA对小鼠的毒性及对L1210白血病的化疗活性。
Eur J Cancer (1965). 1980 Aug;16(8):981-6. doi: 10.1016/0014-2964(80)90243-1.
8
Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.阿霉素（NSC - 123127）和柔红霉素（NSC - 82151）对小鼠乳腺癌的活性。
Cancer Chemother Rep. 1972 Apr;56(2):153-61.
9
Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).ICRF - 159（NSC - 129943）增强柔红霉素（NSC - 82151）或阿霉素（NSC - 123127）对早期小鼠L1210白血病的疗效。
Cancer Chemother Rep. 1975 Jul-Aug;59(4):689-95.
10
Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):258-9.

引用本文的文献

1
Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse.
Cancer Chemother Pharmacol. 1981;5(4):267-70. doi: 10.1007/BF00434396.
2
Absence of delayed lethality in mice treated with aclacinomycin A.阿克拉霉素A治疗的小鼠未出现延迟性致死。
Cancer Chemother Pharmacol. 1981;6(2):161-8. doi: 10.1007/BF00262337.
3
Cancer chemotherapeutics as immunomodulators.作为免疫调节剂的癌症化疗药物。
Springer Semin Immunopathol. 1985;8(4):361-74. doi: 10.1007/BF01857390.
4
The relative toxicity of intravenous and intraperitoneal doses of epirubicin.
Cancer Chemother Pharmacol. 1989;24(4):211-8. doi: 10.1007/BF00257620.
5
The biological characteristics and chemosensitivity of anaplastic thyroid carcinoma transplanted into nude mice.
Jpn J Surg. 1990 Nov;20(6):690-5. doi: 10.1007/BF02471034.